Harvard Heart Letter

Digoxin: Old friend or old foe?

Digoxin is among the oldest cardiac drugs still in use, but its history has been marked by controversy. However, better knowledge of how the drug works has created a potential new role for digoxin in people with advanced heart failure.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In